Vivos (RDGL) Total Debt Growth (1y) (2011 - 2019)
Vivos (RDGL) Total Debt Growth (1y) (2011 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -5.76% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 19.06% |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 7,741.27% |
| Sep 30, 2018 | -91.59% |
| Mar 31, 2018 | -89.58% |
| Sep 30, 2017 | 15.53% |
| Jun 30, 2017 | 15.53% |
| Mar 31, 2017 | -71.15% |
| Dec 31, 2016 | -74.06% |
| Sep 30, 2016 | -68.53% |
| Jun 30, 2016 | -92.67% |
| Mar 31, 2016 | 42.15% |
| Dec 31, 2015 | -71.29% |
| Sep 30, 2015 | 106.12% |
| Jun 30, 2015 | 676.71% |
| Mar 31, 2015 | 167.44% |
| Dec 31, 2014 | 901.71% |
| Sep 30, 2014 | 44.64% |
| Jun 30, 2014 | 98.78% |
| Dec 31, 2013 | 418.67% |
| Sep 30, 2013 | 464.13% |
| Jun 30, 2013 | 154.88% |